31 мар. 2022 г. · Methotrexate, azathioprine, tacrolimus, ciclosporin, and mycophenolate mofetil are to be considered for the treatment of active myositis and ... Scope and purpose · Recommendations · References

Immunosuppressive treatment in combination with exercise is recommended for patients with myositis to reduce disease activity and improve muscle performance.

2 авг. 2017 г. · Myositis specialists defined the degree of clinically meaningful improvement in CSM for minimal, moderate and major improvement. The conjoint- ...

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report | RMD Open.

To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups.

EULAR recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.

31 мар. 2022 г. · BSR launches new myositis guideline. 31 March 2022. We've published a new guideline for clinicians on the treatment and management of myositis.

2 дек. 2021 г. · Dr. Lundberg said the recommended second-line therapy is mycophenolate mofetil (MMF), tacrolimus or cyclosporine or combination therapy of methotrexate and ...

Published Initiatives. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Published: 18 March, 2024 ​ ...

15 сент. 2018 г. · Immunosuppressive treatment in combination with exercise is recommended for patients with myositis to reduce disease activity and improve muscle performance.